loading...

GSE Filings - Intravenous Infusions

2017 Releases

PR - 052 IIL Intravenous Infusions New Managing Director and General Manager (A, R)
PR - 160 IIL Intravenous Infusions Change in Managing Director (A)
PR - 182 IIL Audited Financial Statements for the Full Year (12 Months) Ended December 2016 (A, R, GSE FBTF)
PR - 200 IIL Notice of Annual General Meeting (A, R)
PR - 290 IIL Unaudited Financial Statements for the Half Year (Six Months) Ended June 2017 (A, R)



2016 Releases

PR - 045 IIL Intravenous Infusions Unaudited Financials for the Full Year (12 Months) Ended December 2015 (A, R)
PR - 088 IIL Intravenous Infusions Audited Financials for the Full Year (12 Months) Ended December 2015 (A, R)
PR - 163 IIL AGM Announcement (A, R)
PR - 265 IIL Unaudited Financial Statements for the Half Year (Six Months) Ended June 2016 (A, R)
PR - 355 IIL Unaudited Financial Statements for the Nine Months Ended September 2016 (A, R)



2015 Releases

PR - 069 IIL Intravenous Infusions IPO (A)
PR - 376 IIL Intravenous Infusions IPO Results (A, R)



A - GSE Announcement
R - Company Release



Go Back

created by XDC Express